Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-036773
Filing Date
2013-06-26
Accepted
2013-06-26 16:05:27
Documents
1
Period of Report
2013-06-24

Document Format Files

Seq Description Document Type Size
1 rrd384230.html 4  
1 rrd384230.xml 4 7724
  Complete submission text file 0001181431-13-036773.txt   9231
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address ONE KENDALL SQUARE SUITE B14402 CAMBRIDGE MA 02139
Business Address
REYNOLDS FRANCIS (Reporting) CIK: 0001503383 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 13934546